Consumer Automotive Finance Inc.
(CAFI) Completes Final Steps with FINRA, Expects Name and Ticker
Change to Fifty 1 Labs, Inc. (FITY) Within 30 Days
Melbourne, FL --
February 20, 2025 -- InvestorsHub NewsWire -- Consumer Automotive
Finance Inc. (OTC:
CAFI) is pleased to announce that it has successfully responded
to all final inquiries from the Financial Industry Regulatory
Authority (FINRA) regarding its corporate name and ticker symbol
change. The company anticipates that the transition to Fifty 1
Labs, Inc. (OTC: FITY) will be finalized within the next 30
days.
Led by former NFL
standout Brandon Spikes, Fifty 1 Labs, Inc. represents a new era of
cutting-edge sports nutrition and performance innovation, aligning
with the company's rapid expansion and diversified portfolio. In
addition to its advanced sports supplement division, the company
operates Drago Knives, a premium blade manufacturer, and The
Quickness, a performance training brand focused on speed and
agility.
"The rebrand to
Fifty 1 Labs, Inc. reflects our evolution and commitment to
redefining sports performance, nutrition, and innovation," said
Brandon Spikes, President of Fifty 1 Labs, Inc. "This transition
better aligns with our mission and positions us for accelerated
growth in the sports and lifestyle sectors."
The anticipated
name and ticker change underscore the company's strategic shift
beyond its origins, ensuring greater visibility and market
recognition for its expanding product lines. Management believes
this move will enhance shareholder value and drive new
opportunities in the sports, fitness, and tactical gear
industries.
Further updates
will be provided as the company receives official confirmation from
FINRA.
For more
information, please visit https://fifty1labs.com/.
About Fifty 1 Labs, Inc.
Consumer Automotive
Finance, Inc. (OTCPK:
CAFI), soon to be renamed Fifty 1 Labs, Inc., is a publicly
traded company focused on sports supplementation, fitness
equipment, and holistic wellness. The company operates four key
subsidiaries: 51, LLC, which specializes in sports supplements; The
Quickness, which offers patented athletic training equipment;
Astound NMN, a leader in anti-aging and DNA repair supplements; and
Drago Knives, patented knife throwing technology. Fifty 1 Labs,
Inc. is also actively pursuing strategic acquisitions to expand its
portfolio and drive sustainable growth.
Safe Harbor
Statement:
The information
provided in this release may contain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. Identifiable by words such as "may," "will," "should,"
"plans," "expects," "anticipates," "continue," "estimate,"
"project," "intend," and similar expressions, these statements may
also be made in written or oral form in the company's filings with
the U.S. Securities and Exchange Commission, OTC Markets, press
releases, other written materials, or in oral statements made by
its officers, directors, or employees to third parties. There can
be no assurance that such statements will prove to be accurate. The
company cautions that these forward-looking statements are further
qualified by other factors including, but not limited to, those set
forth in the company's Disclosure Statements. Forward-looking
statements involve risks and uncertainties that could cause actual
results to differ materially from those projected or anticipated.
These risks and uncertainties include, but are not limited to,
general economic and business conditions, effects of continued
geopolitical unrest and regional conflicts, competition, changes in
technology and methods of marketing, delays in completing various
engineering and manufacturing programs, changes in customer order
patterns, changes in product mix, continued success in
technological advances and delivering technological innovations,
shortages in components, production delays due to performance
quality issues with outsourced components, and various other
factors beyond the company's control. The company does not
undertake any obligation to update publicly or to revise any
statements in this release, whether as a result of new information,
future events, or otherwise.
Investor Relations
Contact:
Investor
Relations
877-814-4188
ir@fifty1labs.com
